References
- Kahan B D., Shaw L M., Holt D, Grevel J, Johnston A. Concensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclo-sporine. Clin Chem 1990; 36: 1510–6
- Wang P, Meucci V, Simpson E, Morrison M, Lunetta S, Zajac M, Boeckx R. A monoclonal antibody fluorescent polarization immunoassay for cyclosporine. Transplant Proc 1990; 22: 1186–8
- Yatscoff R W., Copeland K R., Faraci C J. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem 1990; 36: 1969–73
- Klotz U. Comparison of Cyclosporine Blood Levels Measured by Radioimmunoassay and TDx Assay Using Monoclonal Antibodies. Ther Drug Monit 1992; 13: 461–3
- Chan G L., Weinstein S S., Le For W W., Spoto E, Kahana L, Shires D L. Relative performance of specific and nonspecific fluorescence polarization immunoassay for cyclosporine in transplant patients. Ther Drug Monit 1992; 14: 42–7
- Tredger J M., Gonde C E., Williams R. Monitoring cyclosporine in liver-transplant recipients: Effects of clinical status on the performance of two monoclonal antibody-based methods. Clin Chem 1992; 38: 108–13
- Winkler M, Schumann G, Petersen D, Oellerich M, Wonigeit K. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart and liver transplantation. Clin Chem 1992; 38: 123–6
- Schran H F., Rosano T G., Hassell A E., Pell M A. Determination of cyclosporine concentrations with monoclonal antibodies. Clin Chem 1987; 33: 2225–9
- Copeland K R., Yatscoff R W. Use of a monoclonal antibody for the therapeutic monitoring of cyclosporine in plasma and whole blood. Ther Drug Monit 1988; 10: 453–8
- Airman D G., Gardner M J. Calculating confidence intervals for regression and correlation. Statistics with confidence, M J. Gardner, D G. Altman. Br Med J, London 1989; 34–49